COMP <GO>
IVA vs CRVS // 10Y YIELD & FRED MACRO BETA
Inventiva S.A. American Depository Shares (NASDAQ) VS. Corvus Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: IVA 2
— CRVS 0
■ METRIC PARITY
LAST: $3.73 (+0.54%) • MKT CAP: $881.3M
macro-sensitivity
—
LAST: $10.23 (-2.76%) • MKT CAP: $860.6M
macro-sensitivity
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IVA VS. CRVS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IVA | CRVS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -35.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | -3.83% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 2/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.8 | 39.6 | +14.16 | IVA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $881.3M | $860.6M | $20.8M | IVA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IVA REV | CRVS REV | IVA GROSS % | CRVS GROSS % | IVA FCF | CRVS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $0 | — | — | — | -$33.0M |
| FY 2024 | — | $0 | — | — | — | -$25.4M |
| FY 2023 | — | $0 | — | — | — | -$23.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IVA // BETA —
CRVS // BETA —